Glasgow-based HealthTech Talking Medicines has appointed marketing veteran Mike Strassberg as its new chief customer officer to drive US growth.
Talking Medicines is on a mission to be the gold standard in patient intelligence by medicine through its artificial intelligence (AI) technology.
Strassberg is the Scottish company’s first US-based appointment and joins having led sales and marketing at Eversana Intouch B2D for the last three years.
With 30 years of experience in the health and life sciences industry Strassberg has been tasked with helping Talking Medicines establish its AI platform PatientMetRx as the premier digital source of patient voice for medical marketers and agencies.
Based in New York, he will focus on new customer acquisition and will work closely with current customers to help them maximise the value of their platform subscriptions.
Talking Medicines opened its New Jersey office earlier this year and has already secured contracts with a number of leading US-based medical advertising agencies.
Strassberg said: “Building a patient-centric commercial organisation has become a necessity for life sciences companies, and by extension their marketing agencies, but until now there has been limited insight into actual patient experiences.
“The PatientMetRx cloud-based software, powered by Talking Medicines’ AI enabled platform, provides a unique view of the patient voice, which can illuminate the patient perspective, delivering better health outcomes.”
Jo Halliday, co-founder, and CEO of Talking Medicines said: “Just as Talking Medicines is the voice of patients, Mike will be the voice of our customers, providing a consistent and seamless experience, driving growth, establishing new relationships, managing current accounts, and building a global customer-centric organisation.
“With extensive experience in the sector Mike will open doors for us and continue to expand our network. I am looking forward to collaborating closely with him as we enter an exciting phase in the growth of the business.”
Talking Medicines is led by Halliday, alongside Dr Elizabeth Fairley and Dr Scott Crae. It was founded upon the principle of being a ‘data for good’ business with the social mission of delivering better health outcomes for patients.